Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
About AAPS 2024 PharmSci 360
The AAPS 2024 PharmSci 360 is an annual event organized by the American Association of Pharmaceutical Scientists (AAPS). This conference is a key gathering for pharmaceutical science professionals, bringing together researchers, industry leaders, and academics from around the globe to discuss the latest advancements in pharmaceutical science and technology.
AAPS 2024 PharmSci 360 aims to foster the exchange of scientific knowledge and promote the application of this knowledge to develop products that improve global health. This year’s themes will focus on discovery and basic research, preclinical, clinical, and translation sciences, bioanalytics, manufacturing and analytical characterization, and formulation and delivery.
Date: October 20-23, 2024
Format: In-person
Location: Salt Palace Convention Center
Booth number: #1620
Event website:
https://www.aaps.org/pharmsci/annual-meeting
Please fill out the form below, including the topic you are interested in, and we will be in touch.
Let’s connect at AAPS 2024 PharmSci 360 from October 20-23
When it comes to oral solid dose product development and manufacturing, it’s important to know what’s ahead. Know your regulatory landscape. Know potential issues to overcome. Know your formulation challenges. Know your project’s likelihood of success.
At Thermo Fisher Scientific, we’ve been down this road before. Having developed three of the top eight best-selling small molecule drugs, we can provide unparalleled insight into the challenges that lie ahead, as well as the opportunities you’re likely to encounter.
Visit booth #1620 to explore our comprehensive CDMO capabilities specifically for small molecule drugs and oral solid dose products. From formulation development to commercial manufacturing and beyond, we have the expertise to solve your scientific challenges.